Dairy Cow Nutrition: Diagnostic Approach to Metabolic Disorders

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Ketosis and Hepatic Lipidosis: These disorders stem from excessive nonesterified fatty acid (NEFA) mobilization during negative energy balance, leading to hyperketonemia and/or triglyceride accumulation in the liver. Primary ketosis is due to inadequate energy intake, while secondary ketosis is triggered by concurrent diseases (e.g., abomasal displacement, mastitis) that suppress feed intake.
• Hypocalcemia: Abruptly high calcium demands for colostrum and milk production, coupled with a lag in adaptive mechanisms (parathyroid hormone and vitamin D axis), result in hypocalcemia. Dietary factors, particularly potassium content, significantly influence the cow's ability to adapt to this demand.
• Diagnostic Tools: Key diagnostic parameters include serum or plasma beta-hydroxybutyrate (BHB) for ketosis, serum calcium for hypocalcemia, and rumen fluid pH via rumenocentesis for subacute rumen acidosis (SARA). Milk BHB and acetone measured by Fourier-transform infrared spectroscopy (FTIR) offer valuable population-level screening.
• Inflammatory and Environmental Interactions: Metabolic disorders are often compounded by systemic inflammation, which can be triggered by rumen acidosis and endotoxin translocation, or by heat stress, which shares metabolic pathways with ketosis. Acute phase proteins like haptoglobin and serum amyloid A indicate systemic inflammation.
• Signalment and Clinical Examination: Signalment (age, parity, days in milk) stratifies risk, with hypocalcemia more common in older cows and ketosis/hepatic lipidosis in early lactation. Clinical signs range from anorexia and reduced milk production to neurological signs and recumbency, requiring careful differentiation from other conditions.
• Laboratory Confirmation and Emerging Technologies: While point-of-care tests are crucial, laboratory confirmation of BHB, NEFA, glucose, and liver enzymes provides objective data. Metabolomic profiling is an emerging tool for distinguishing hepatic lipidosis stages and identifying heat stress, though not yet routine in practice.

This article provides a diagnostic framework for the principal metabolic disorders of transition dairy cows: ketosis, hepatic lipidosis, hypocalcemia, and subacute rumen acidosis. It is written for practicing veterinarians who require a structured approach to case investigation, from signalment and history through physical examination, point-of-care testing, and laboratory confirmation. The emphasis is on diagnostic reasoning, differential prioritization, and interpretation of results in the context of herd-level and individual-animal data. Treatment protocols are deliberately excluded.

The clinical questions addressed are direct: Is this cow ketotic, and if so, is the ketosis primary or secondary? Does this cow have hypocalcemia, and what is the severity relative to clinical signs? Is hepatic lipidosis present, and how does it modify prognosis? What role does rumen acidosis play in the presenting signs? Answering these questions requires integrating metabolic physiology with practical diagnostic tools and an awareness of the limitations of each test.

At a Glance

Metabolic Physiology of the Transition Period

The transition from late gestation to early lactation imposes competing metabolic demands. The fetus consumes glucose and amino acids, while the mammary gland begins to drain glucose, amino acids, and calcium. Dry matter intake typically falls in the final week before calving, and the postpartum increase in intake lags behind the rise in milk production. The resulting negative energy balance drives adipose tissue lipolysis, releasing nonesterified fatty acids (NEFA) into circulation.

The liver takes up NEFA and partitions them among three fates: complete oxidation to carbon dioxide, partial oxidation to ketone bodies, or re-esterification to triglycerides. When NEFA flux exceeds hepatic oxidative capacity, ketone body production rises and triglycerides accumulate within hepatocytes. The balance between these pathways determines whether a cow develops hyperketonemia, hepatic lipidosis, or both. Perilipin 1 regulates this lipid metabolism homeostasis in bovine adipocytes, and its downregulation in ketotic cows promotes lipolysis and activates inflammatory signaling through the NF-κB pathway.

Calcium homeostasis operates on a different timescale. The abrupt onset of lactation demands 20 to 30 g of calcium daily for colostrum and milk synthesis, while the cow's exchangeable calcium pool is only a fraction of that amount. The parathyroid hormone and vitamin D axis must upregulate intestinal absorption and bone resorption within hours. Failure of this adaptation produces hypocalcemia, with clinical severity ranging from subclinical depression to recumbency and coma. Dietary factors, particularly potassium content, influence the cow's ability to adapt, which explains why dry cow nutrition so strongly predicts milk fever risk.

Pathophysiology of Ketosis and Hepatic Lipidosis

Ketosis and hepatic lipidosis are best understood as two expressions of the same underlying problem: excessive NEFA mobilization with incomplete hepatic adaptation. Primary ketosis occurs when energy intake is simply inadequate relative to demand. Secondary ketosis arises when another disease, most commonly abomasal displacement, mastitis, or metritis, suppresses feed intake in an already vulnerable cow. The distinction matters diagnostically because secondary ketosis does not resolve until the inciting disease is identified and addressed.

Hepatic lipidosis represents the severe end of the same spectrum. Triglyceride accumulation exceeding roughly one-third of liver weight defines the condition histologically. The clinical signs are nonspecific: progressive inappetence, weight loss, and weakness that may be mistaken for primary ketosis or another chronic disease. Metabolomic profiling has identified serum amino acid and lipid patterns that distinguish affected cows from healthy controls, but these profiles are not yet available in routine practice. Liver biopsy remains the definitive diagnostic method, though it is invasive and impractical for herd-level screening.

Inflammatory Interactions in Metabolic Disease

The metabolic disorders of transition cows do not occur in isolation. Rumen digestive disorders and diet-induced inflammation are closely linked, and the same review describes how subacute rumen acidosis can disrupt gastrointestinal barrier function, allowing endotoxin translocation and triggering a systemic acute phase response. This inflammatory state compounds the metabolic stress of negative energy balance and may worsen ketosis through cytokine-mediated effects on appetite and hepatic function.

The clinical implication is that a cow with ketosis and elevated acute phase proteins should be investigated for concurrent rumen acidosis, mastitis, metritis, or other inflammatory foci. Conversely, a cow with subacute rumen acidosis may present with reduced feed intake and secondary ketosis. The diagnostic workup must therefore consider both metabolic and inflammatory contributors to the clinical picture.

Heat Stress as a Metabolic Stressor

Heat stress imposes an additional metabolic burden that can mimic or exacerbate the classic transition disorders. Metabolomic analysis of heat-stressed lactating cows identified 13 plasma metabolites, including glucose, lactate, pyruvate, acetoacetate, acetone, and beta-hydroxybutyrate, that discriminated affected from unaffected animals. The overlap with ketosis biomarkers is substantial, reflecting shared pathways of carbohydrate and lipid metabolism.

For the diagnostician, this means that environmental conditions must be part of the history. A cow with elevated ketone bodies during hot weather may have heat stress as the primary problem, with ketosis as a secondary consequence of reduced intake. The diagnostic interpretation of ketone thresholds does not change, but the therapeutic and management response differs substantially.

Diagnostic Test Selection and Interpretation

The choice of diagnostic tests depends on whether the question is individual or herd-level. For an individual sick cow, blood sampling for BHB, glucose, calcium, and liver enzymes provides the core metabolic profile. For herd-level investigation, milk FTIR data for BHB and acetone offer a noninvasive screening tool. Large-scale genetic and phenotypic analysis of milk BHB and acetone measured by FTIR has confirmed their association with clinical ketosis, supporting their use in routine test-day programs.

Rumen fluid pH measurement is indicated when subacute rumen acidosis is suspected. Rumenocentesis is the reference method, and pH thresholds for SARA diagnosis are published by consensus bodies. The test is most informative when performed on multiple animals, since individual variation is substantial. The MSD Veterinary Manual provides species-specific guidance on sample collection and interpretation for these metabolic tests.

Clinical Examination and Signalment in Metabolic Disease Diagnosis

The physical examination begins with signalment, because age, parity, and days in milk stratify the probability of specific disorders. Hypocalcemia occurs most often in older cows, particularly those in third lactation or greater, at the onset of lactation. Ketosis and hepatic lipidosis cluster in the first 3 to 6 weeks of lactation, with peak risk in high-yielding cows that carry excessive body condition. The MSD Veterinary Manual provides species-specific guidance on examination technique and interpretation of findings across production species.

The examination should proceed systematically. Assess mentation, posture, and gait before handling the cow, because these observations are lost once the animal is restrained. A cow that is bright but anorexic with a sweet or fruity breath odor suggests ketosis. A cow that is recumbent, depressed, and hypothermic with poor peripheral perfusion suggests severe hypocalcemia. Differentiate these from the downer cow that is alert, eating, and defecating normally, which points toward a traumatic or compressive cause instead of a primary metabolic event.

Rectal temperature, heart rate, respiratory rate, and rumen motility provide immediate discriminative value. Hypocalcemia typically presents with bradycardia, weak heart sounds, and reduced or absent rumen contractions. Ketosis often presents with normal to mildly elevated heart rate and reduced rumen motility. Fever should redirect the differential toward mastitis, metritis, or other infectious processes that can coexist with or mimic metabolic disease.

Point-of-Care Testing and Interpretation

Cow-side ketone testing remains the first-line diagnostic for ketosis. Blood beta-hydroxybutyrate (BHB) measured by handheld meter is the reference point-of-care method. A blood BHB concentration of 1.2 mmol/L or greater is the widely accepted threshold for subclinical ketosis, while clinical ketosis is diagnosed when hyperketonemia is accompanied by signs such as decreased feed intake, decreased milk production, or neurologic signs. Milk ketone testing using test strips or milk meters offers a noninvasive alternative, but milk BHB concentrations run lower than blood concentrations, and the correlation weakens at higher blood values.

The genetic and nongenetic profiling of milk beta-hydroxybutyrate and acetone demonstrates that Fourier-transform infrared spectroscopy (FTIR) of milk can estimate acetone and BHB on a population scale. This technology is valuable for herd-level monitoring and for identifying cows at elevated risk of clinical ketosis, but it does not replace blood testing for individual cow diagnosis when clinical decisions are pending.

Calcium status is assessed with a handheld ionized calcium analyzer or with serum chemistry. Ionized calcium is the physiologically active fraction and is the preferred measurement when available. Total calcium is acceptable when ionized calcium is unavailable, but interpretation must account for albumin and pH effects. Clinical hypocalcemia is diagnosed when ionized calcium falls below approximately 1.0 mmol/L, with recumbency typically developing below 0.7 to 0.8 mmol/L. The strategies for preventing milk fever review emphasizes that clinical signs correlate more closely with the rate of calcium decline and with ionized calcium concentration than with total calcium alone.

Differential Diagnosis Table

Laboratory Confirmation and Metabolomic Markers

Serum chemistry panels provide the objective confirmation that point-of-care testing cannot. For ketosis, measure BHB, nonesterified fatty acids (NEFA), glucose, and liver enzymes. NEFA concentration reflects the degree of fat mobilization and is most informative when sampled before the onset of clinical signs. A NEFA concentration above 0.4 mmol/L in the prepartum period or above 0.7 mmol/L in early lactation identifies cows at increased risk of ketosis and hepatic lipidosis.

Hepatic lipidosis is confirmed by liver biopsy with histologic assessment of triglyceride content. Biopsy is invasive and not always practical in field settings. The metabolomic biomarkers correlating with hepatic lipidosis study identified a panel of 29 serum metabolites, including amino acids, phosphatidylcholines, and sphingomyelins, that distinguished cows with no hepatic lipidosis from those with different stages of the disorder. This approach is not yet available in routine practice, but it indicates that serum-based diagnosis of fatty liver may become feasible.

The identification of diagnostic biomarkers and metabolic pathway shifts of heat-stressed lactating dairy cows work identified 13 plasma metabolites with high sensitivity and specificity for heat stress status, including glucose, lactate, pyruvate, acetoacetate, acetone, and BHB. These findings matter diagnostically because heat-stressed cows can present with metabolic derangements that mimic ketosis. When environmental conditions suggest heat stress, interpret ketone and glucose values with that context in mind.

Documentation and Herd-Level Integration

Individual cow records should capture the date, parity, days in milk, clinical signs, point-of-care results, and laboratory values. Record the specific test method used, because blood and milk ketone thresholds differ. Note the time of sampling relative to feeding and treatment, since both influence metabolite concentrations.

Herd-level monitoring shifts the diagnostic focus from individual cows to populations. Milk FTIR ketone data from routine test-day records can identify cows with elevated acetone or BHB before clinical signs appear. The USDA APHIS animal health information resources describe surveillance frameworks that support this type of population monitoring. Track the proportion of cows exceeding the subclinical ketosis threshold over time, and use this metric to evaluate transition cow management.

When a metabolic disorder is confirmed, document the concurrent conditions that may have triggered it. Ketosis secondary to retained placenta, metritis, or displaced abomasum carries a different prognosis and requires a different diagnostic plan than primary ketosis. The interplay between rumen digestive disorders and diet-induced inflammation review describes how subacute rumen acidosis can increase gastrointestinal permeability and trigger a systemic acute phase response, which in turn worsens metabolic stress. A cow with ketosis and evidence of rumen dysfunction needs evaluation of the ration and feeding management, also treatment of the ketosis itself.

The perilipin 1 mediated lipid metabolism homeostasis work in bovine adipocytes shows that ketotic cows have altered adipose tissue expression of lipid droplet proteins and increased inflammatory cytokine production. This finding supports the clinical observation that ketosis is not an isolated energy deficit but a broader metabolic-inflammatory syndrome. Diagnostic plans should therefore include assessment of inflammatory status when ketosis is severe or recurrent.

Recognized Complications and Early Detection

The principal failure modes in metabolic disease diagnosis are not laboratory errors but interpretive ones. Subclinical ketosis progresses to clinical disease when the practitioner relies on a single urine or milk ketone measurement without serial monitoring. The transition period is dynamic, and a negative test on day 5 post partum does not predict status on day 10. Early detection of deteriorating fat mobilization requires repeated point-of-care testing at fixed intervals, with the threshold for intervention set by the herd's historical incidence instead of by a single cow-side reading.

Hepatic lipidosis presents a more subtle failure mode. Serum chemistry reflects advanced hepatocellular damage, and by the time aspartate aminotransferase and gamma-glutamyl transferase activities rise, the cow has substantial liver fat infiltration. Metabolomic profiling has identified serum amino acid and phospholipid patterns that distinguish fatty liver stages, but this technology is not yet a routine clinical tool. The practical early indicator remains the combination of persistent hyperketonemia beyond the first week of lactation with a poor response to glucose precursors. Cows that remain ketotic despite apparently adequate therapy warrant liver biopsy to confirm lipidosis severity and to guide prognosis.

Inflammatory complications are detected through the acute phase response. Cows with ruminal acidosis and barrier disruption show elevated acute phase proteins, and this systemic inflammation compounds the metabolic disturbance. The discriminating finding is a cow whose ketone values improve but whose appetite and milk yield do not. That dissociation points to an inflammatory component that ketone testing alone will miss.

Common Diagnostic Errors and Corrective Action

The most frequent error in field diagnosis is overinterpreting a single urine ketone reading. Urine acetoacetate reflects renal excretion, which varies with urine concentration and hydration status, and it lags behind blood beta-hydroxybutyrate. A strongly positive urine test in a dehydrated cow may overstate the severity of ketosis, while a negative urine test in early disease may miss a rising blood ketone concentration. Blood beta-hydroxybutyrate measurement is the reference point-of-care method, and milk ketone testing by Fourier-transform infrared spectroscopy provides a herd-level screening alternative with genetic associations to clinical ketosis that support its use in population monitoring.

A second error is attributing recumbency to hypocalcemia without assessing response to therapy. Cows with milk fever that do not rise after calcium administration are frequently misclassified as treatment failures when the actual diagnosis is a calving-related musculoskeletal injury or a concurrent electrolyte disturbance. The corrective action is a structured reassessment: evaluate serum calcium, magnesium, and phosphorus, examine the hindlimbs for fractures or nerve damage, and reconsider the differential diagnosis before repeating treatment.

A third error is ignoring the dietary history when interpreting test results. A cow with elevated ketones on a diet that is already well formulated for the transition period has a different problem than one on an oversupplied energy diet. The diagnostic workup must include a ration assessment, because the metabolic test result only identifies the phenotype, not the nutritional cause.

Limitations of the Evidence and Areas of Expert Disagreement

The evidence base for metabolic disease diagnosis rests heavily on observational studies and physiological reasoning instead of on large intervention trials. Diagnostic thresholds for hyperketonemia vary between reference sources, and the optimal cut point for predicting disease outcomes remains contested. Some authorities advocate a blood beta-hydroxybutyrate threshold of 1.2 mmol/L for subclinical ketosis, while others use 1.4 mmol/L, and the choice materially affects herd prevalence estimates.

The role of inflammation in metabolic disease pathogenesis is established in principle, but the clinical utility of inflammatory markers for individual cow diagnosis is not. Whether acute phase protein measurement should guide treatment decisions or only inform prognosis is unresolved. Similarly, the metabolomic biomarker panels described in research settings have not been validated across production systems, and their positive and negative predictive values in field populations are unknown.

Expert opinion also differs on the value of routine liver biopsy. Some clinicians reserve biopsy for research or terminal cases, while others use it to stage lipidosis and guide culling decisions. The procedure carries risk, and the information gained must be weighed against the cost and the potential for complications.

Referral, Consultation, and Reporting

Most metabolic disease cases are managed on farm, but referral is warranted when the cow fails to respond to standard therapy, when the clinical picture suggests a concurrent surgical condition such as abomasal displacement, or when recumbency persists beyond 48 hours despite correction of electrolyte abnormalities. Specialist consultation with a veterinary nutritionist is appropriate when herd-level incidence exceeds target thresholds, because the problem is usually dietary formulation instead of individual cow physiology.

Laboratory involvement is indicated when point-of-care results conflict with clinical findings, when the practitioner suspects a rare metabolic error, or when herd-level monitoring requires standardized measurements across multiple samplings. A diagnostic laboratory can provide the reference methods and quality assurance that cow-side testing lacks.

Regulatory reporting obligations vary by jurisdiction. Metabolic disorders of dairy cattle are not generally reportable diseases, but practitioners should confirm local requirements through the relevant animal health authority. The USDA APHIS animal health information and the WOAH terrestrial animal health standards provide guidance on surveillance and reporting expectations in their respective regions.

Frequently Asked Questions

How Do I Prioritize Testing When Laboratory Access Is Delayed or Cost-Limited?

Start with physical examination findings and point-of-care ketone testing, as these provide immediate diagnostic direction. Milk or blood beta-hydroxybutyrate measurement identifies subclinical ketosis before clinical signs appear, and Fourier-transform infrared spectroscopy of milk offers a practical population-level screening tool where available. When confirmatory laboratory testing is unavailable, document response to supportive care and monitor progression over 24 to 48 hours. For suspected hepatic lipidosis, serum metabolomic profiles may eventually offer a noninvasive alternative to biopsy, but this approach remains primarily a research tool. Reserve expensive or specialized testing for cases where the diagnosis remains uncertain after basic evaluation, and prioritize conditions that require immediate intervention to prevent deterioration.

What Minimum Equipment Should a Practice Carry for Metabolic Disease Workups in Dairy Cattle?

A reliable glucometer validated for bovine blood, a ketone meter capable of measuring beta-hydroxybutyrate in blood or milk, and a thermometer form the diagnostic core. A stethoscope and rumen auscultation skills remain essential for differentiating metabolic from gastrointestinal disease. For hypocalcemia assessment, response to calcium administration can serve as a diagnostic test when laboratory confirmation is unavailable, but this should be done cautiously in cows with suspected concurrent cardiac disease. Practices serving dairy clients should also carry equipment for aseptic blood collection and sample preservation, as transport to a diagnostic laboratory is often necessary for definitive confirmation of hepatic lipidosis or other complex metabolic derangements.

How Does the Diagnostic Approach Differ in Beef Cows or Small Ruminants Presenting with Similar Signs?

The transition period physiology that predisposes dairy cattle to ketosis and hypocalcemia is less pronounced in beef cows, where lower milk production reduces metabolic demand. However, beef cows with inadequate body condition or forced early weaning can develop pregnancy toxemia, which shares pathophysiologic features with dairy ketosis. Small ruminants, particularly ewes and does carrying multiple fetuses, are at higher risk for pregnancy toxemia, and the diagnostic emphasis shifts toward assessing fetal number and body condition. Hypocalcemia in beef cows is more commonly associated with transport or handling stress instead of lactation onset. The same point-of-care tests apply across species, but interpretation thresholds for beta-hydroxybutyrate differ, and current species-specific references should be consulted.

What Records Should I Maintain for Metabolic Disease Cases to Support Herd-Level Diagnosis?

Record signalment, parity, days in milk, body condition score, and all point-of-care test results with timestamps. Document the physical examination findings that supported the diagnosis, including temperature, heart rate, rumen motility, and neurologic status. Note any treatments administered and the temporal response, as this information informs both individual case management and future diagnostic decisions. For herd-level analysis, maintain a rolling log of all metabolic disease cases with their associated test values, as population-level health trait recording improves the ability to detect emerging problems. Standardized records allow pattern recognition across seasons, feeding groups, and parity classes, which supports earlier intervention in subsequent lactation cycles.

How Should I Explain a Metabolic Disease Diagnosis to a Herd Owner Who Wants a Simple Explanation?

Frame the explanation around the cow's energy and mineral balance instead of complex pathophysiology. Explain that the cow cannot consume enough feed to meet the sudden demands of milk production, so her body mobilizes fat reserves, and the byproducts of that fat breakdown accumulate when mobilization outpaces the liver's processing capacity. For milk fever, explain that the sudden calcium demand of colostrum production temporarily exceeds the cow's ability to mobilize calcium from bone. Use the cow's own test results to make the explanation concrete, showing the owner the beta-hydroxybutyrate value or calcium level and comparing it to the reference range. Emphasize that these conditions reflect management and transition period nutrition instead of infectious disease, which helps owners focus on preventive strategies.

When Should I Refer a Metabolic Disease Case to a Specialist or Diagnostic Laboratory?

Refer or seek laboratory confirmation when clinical signs progress despite appropriate supportive care, when the presentation is atypical, or when multiple cows in the same group develop similar signs within a short period. Cases with concurrent disease, such as mastitis or retained placenta, may require more extensive diagnostic evaluation than uncomplicated metabolic disease. Institutional guidance on livestock disease surveillance supports early reporting of unusual disease patterns, and herd-level outbreaks of metabolic disease may indicate ration formulation problems that warrant nutritional consultation. Liver biopsy for histologic confirmation of hepatic lipidosis should be considered when serum chemistry is equivocal or when the cow fails to respond to treatment, as the prognosis and management differ substantially from uncomplicated ketosis.

Related Clinical & Scientific Guides

• Rumen Health Assessment in Dairy Cows: Clinical and Subclinical Indicators
• Mastitis Control Programs in Dairy Herds: Monitoring and Prevention
• Swine Nutrition and Health: Feed-Related Disease Diagnosis

References and Further Reading

• Interplay between rumen digestive disorders and diet-induced inflammation in dairy cattle.. 2012.
• Identification of diagnostic biomarkers and metabolic pathway shifts of heat-stressed lactating dairy cows.. 2015.
• Perilipin 1 Mediates Lipid Metabolism Homeostasis and Inhibits Inflammatory Cytokine Synthesis in Bovine Adipocytes.. 2018.
• Genetic and nongenetic profiling of milk β-hydroxybutyrate and acetone and their associations with ketosis in Holstein cows.. 2020.
• Strategies for preventing milk fever in dairy cattle.. 1997.
• Metabolomic biomarkers correlating with hepatic lipidosis in dairy cows.. 2014.
• USDA APHIS Animal Health Information. USDA APHIS.
• FAO Animal Production and Health. FAO.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Diagnostic Approach to Downer Cow Syndrome: Metabolic vs. Traumatic Causes
• Diagnostic Approach to Weight Loss in Adult Dairy Cows: Parasitism, Nutrition, and Chronic Disease
• Dairy Calf Health: Diagnostic Approach to Neonatal Diarrhea
• Diagnostic Approach to Lameness in Dairy Cattle: Lesion Localization
• Diagnostic Approach to Downer Sow Syndrome: Metabolic, Traumatic, and Infectious Causes

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.